Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monique Hinchcliff

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 10, 2021
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort StudyDennis G Moledina, Michael Simonov, Yu Yamamoto, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2022
A Novel MIP-1-Expressing Macrophage Subtype in BAL Fluid from Healthy VolunteersPaul A Reyfman, Elizabeth S Malsin, Basil Khuder, et al.
BMJ (Clinical Research Ed.)|January 19, 2021
Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trialF Perry Wilson, Melissa Martin, Yu Yamamoto, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Lancet. Respiratory Medicine|April 3, 2019
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine K D Scott, Katie Quinn, Qin Li, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
A Nerve-Fibroblast Axis in Mammalian Lung FibrosisGenta Ishikawa, Xueyan Peng, Alexander Ghincea, et al.
Nature Reviews. Rheumatology|March 3, 2025
Publisher Correction: An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 10, 2021
The Association of COVID-19 With Acute Kidney Injury Independent of Severity of Illness: A Multicenter Cohort StudyDennis G Moledina, Michael Simonov, Yu Yamamoto, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2022
A Novel MIP-1-Expressing Macrophage Subtype in BAL Fluid from Healthy VolunteersPaul A Reyfman, Elizabeth S Malsin, Basil Khuder, et al.
BMJ (Clinical Research Ed.)|January 19, 2021
Electronic health record alerts for acute kidney injury: multicenter, randomized clinical trialF Perry Wilson, Melissa Martin, Yu Yamamoto, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma PatientsHadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, et al.
The Lancet. Rheumatology|April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort studyMonique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Lancet. Respiratory Medicine|April 3, 2019
Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine K D Scott, Katie Quinn, Qin Li, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
A Nerve-Fibroblast Axis in Mammalian Lung FibrosisGenta Ishikawa, Xueyan Peng, Alexander Ghincea, et al.
Nature Reviews. Rheumatology|March 3, 2025
Publisher Correction: An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung DiseaseShervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Pageof 12